Related Experiment Video
Updated: Jul 19, 2026
12:04
Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 6, 2011
Surgical therapy for Parkinson's disease
A L Benabid1, S Chabardès, E Seigneuret
1University Joseph Fourier, INSERM U318, Grenoble, France. Alim-Louis.Benabid@ujf-grenoble.fr
Journal of Neural Transmission. Supplementum
|October 5, 2006
Summary
High frequency stimulation (HFS) of the subthalamic nucleus (STN) effectively treats Parkinson
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- High frequency stimulation (HFS) offers a reversible, adaptable, low-morbidity alternative to medical therapy for Parkinson's disease.
- HFS applications evolved from the thalamus (Vim) to the Pallidum (GPi) and subsequently the subthalamic nucleus (STN).
- Subthalamic nucleus HFS (STN-HFS) is now widely used due to its efficacy in managing tremor, rigidity, and bradykinesia.
Purpose of the Study:
- To review the application and efficacy of STN-HFS in Parkinson's disease management.
- To explore the predictive factors for successful STN-HFS outcomes.
- To investigate the potential neuroprotective mechanisms of STN-HFS.
Main Methods:
- Review of existing literature on HFS in Parkinson's disease, focusing on STN-HFS.
- Analysis of criteria for patient selection and electrode placement.
- Examination of factors predicting treatment response, such as Levodopa responsiveness.
Main Results:
- STN-HFS demonstrates high efficiency in alleviating Parkinson's disease motor symptoms.
- Successful patient selection and precise electrode placement are critical for optimal outcomes.
- Levodopa response is a key predictor of STN-HFS success.
Conclusions:
- STN-HFS is a highly effective treatment for Parkinson's disease motor symptoms.
- Potential neuroprotective effects, possibly via glutamate inhibition in the STN, warrant further investigation.
- Clinical trials are recommended to confirm the neuroprotective potential of STN-HFS in Parkinson's disease patients.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:30Psychosurgery
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...